Medications originally developed to treat cardiovascular conditions may soon become a powerful new weapon against liver cancer. This groundbreaking discovery comes from scientists at the University of Mississippi and Suresh Gyan Vihar University, who investigated a class of natural compounds known as cardiac glycosides. Their findings were published in the journal Pharmacological Research — Natural Products (PRNP).
The research team uncovered that these plant-derived glycosides possess the ability to interact with specific proteins and genes implicated in the progression of hepatocellular carcinoma — the most prevalent form of liver cancer. Employing an advanced network pharmacology approach, they successfully identified five potential compounds that could effectively disrupt key survival mechanisms within cancerous cells.
Scientists highlight that naturally sourced compounds like cardiac glycosides often present a reduced risk of adverse effects when compared to conventional chemotherapy treatments. According to the authors, this significant breakthrough establishes a foundation for the development of innovative and potentially safer therapeutic options for one of the most deadly forms of cancer.
In a related finding, previous research indicated that regular consumption of tea could lower the risk of developing liver cancer by almost half.
